RedHill Biopharma reported $5.51M in Operating Expenses for its fiscal quarter ending in June of 2024.


Operating Expenses Change Date
Clal Biotechnology ILS 5.15M 9.47M Dec/2022
Compugen USD 9.69M 736K Jun/2025
Cronos Group USD 37.84M 1.5M Jun/2025
RedHill Biopharma USD 5.51M 1.08M Jun/2024